Phase I study of sapanisertib with carboplatin and paclitaxel in mTOR pathway altered solid malignancies

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I study of sapanisertib with carboplatin and paclitaxel in mTOR pathway altered solid malignancies'. Together they form a unique fingerprint.

Medicine & Life Sciences